BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1295322)

  • 1. Gd-DOTA loaded into red blood cells, a new magnetic resonance imaging contrast agents for vascular system.
    Kravtzoff R; Urvoase E; Chambon C; Ropars C
    Adv Exp Med Biol; 1992; 326():347-54. PubMed ID: 1295322
    [No Abstract]   [Full Text] [Related]  

  • 2. Size-stable solid lipid nanoparticles loaded with Gd-DOTA for magnetic resonance imaging.
    Andreozzi E; Wang P; Valenzuela A; Tu C; Gorin F; Dhenain M; Louie A
    Bioconjug Chem; 2013 Sep; 24(9):1455-67. PubMed ID: 24004269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential fast 3D MRI following oral ingestion of Gd-DOTA: A new means to assess intestinal transit time.
    Patak MA; Weishaupt D; Fröhlich JM; Debatin JF
    J Magn Reson Imaging; 1999 Sep; 10(3):474-6. PubMed ID: 10508311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial concentration profiles of two blood pool agents and Gd-DOTA after intravenous injection in rabbits.
    Corot CA; Violas X; Robert P; Port M
    Acad Radiol; 2002 May; 9 Suppl 1():S137-9. PubMed ID: 12019850
    [No Abstract]   [Full Text] [Related]  

  • 5. Review of the use of high-dose gadoteridol in the magnetic resonance evaluation of central nervous system tumors.
    Yuh WT; Fisher DJ; Mayr-Yuh NA; Tali ET; Nguyen HD; Gao F; Ehrhardt JC
    Invest Radiol; 1992 Aug; 27 Suppl 1():S39-44. PubMed ID: 1506152
    [No Abstract]   [Full Text] [Related]  

  • 6. Design of a Gd-DOTA-phthalocyanine conjugate combining MRI contrast imaging and photosensitization properties as a potential molecular theranostic.
    Aydın Tekdaş D; Garifullin R; Şentürk B; Zorlu Y; Gundogdu U; Atalar E; Tekinay AB; Chernonosov AA; Yerli Y; Dumoulin F; Guler MO; Ahsen V; Gürek AG
    Photochem Photobiol; 2014; 90(6):1376-86. PubMed ID: 25131633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal handling and physiologic effects of the paramagnetic contrast medium Gd-DOTA.
    Katzberg RW; Sahler LG; Duda SW; Morris TW; McKenna BA; Pabico RC; Niedrach WL; Tonetti FW
    Invest Radiol; 1990 Jun; 25(6):714-9. PubMed ID: 2354935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-pool magnetic resonance imaging contrast agents. New developments.
    Doucet D; Urvoas E; Kravtzoff R; Chambon C; Schoumann-Claeys E; Frija G; Ropars C
    Invest Radiol; 1991 Nov; 26 Suppl 1():S46-7; discussion S60-4. PubMed ID: 1808148
    [No Abstract]   [Full Text] [Related]  

  • 9. MR angiography with a new rapid clearance blood pool agent (P792): initial experience in rabbits.
    Ruehm SG; Schmitz-Cristina H; Violas X; Corot C; Debatin JF
    Acad Radiol; 2002 Aug; 9 Suppl 2():S407-8. PubMed ID: 12188291
    [No Abstract]   [Full Text] [Related]  

  • 10. A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent.
    Ye Z; Zhou Z; Ayat N; Wu X; Jin E; Shi X; Lu ZR
    Contrast Media Mol Imaging; 2016; 11(1):32-40. PubMed ID: 26218648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyion complex micelle MRI contrast agents from poly(ethylene glycol)-b-poly(l-lysine) block copolymers having Gd-DOTA; preparations and their control of T(1)-relaxivities and blood circulation characteristics.
    Shiraishi K; Kawano K; Maitani Y; Yokoyama M
    J Control Release; 2010 Dec; 148(2):160-7. PubMed ID: 20804796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An MRI Method To Map Tumor Hypoxia Using Red Blood Cells Loaded with a pO2-Responsive Gd-Agent.
    Di Gregorio E; Ferrauto G; Gianolio E; Lanzardo S; Carrera C; Fedeli F; Aime S
    ACS Nano; 2015 Aug; 9(8):8239-48. PubMed ID: 26234938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial delayed enhancement using a single dose (0.1 mmol/kg) of gadobenate dimeglumine: contrast resolution versus intraventricular blood and viable myocardium.
    Papini GD; Tritella S; Secchi F; Aliprandi A; Di Leo G; Sardanelli F
    Radiol Med; 2010 Aug; 115(5):693-701. PubMed ID: 20221713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast enhanced lung MRI in mice using ultra-short echo time radial imaging and intratracheally administrated Gd-DOTA-based nanoparticles.
    Bianchi A; Lux F; Tillement O; Crémillieux Y
    Magn Reson Med; 2013 Nov; 70(5):1419-26. PubMed ID: 23233439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved evaluation of myocardial perfusion and viability with the magnetic resonance blood pool contrast agent p792 in a nonreperfused porcine infarction model.
    Peukert D; Kaufels N; Laule M; Schnorr J; Carme S; Farr T; Schönenberger E; Taupitz M; Hamm B; Dewey M
    Invest Radiol; 2007 Apr; 42(4):248-55. PubMed ID: 17351432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrimination of myocardial acute and chronic (scar) infarctions on delayed contrast enhanced magnetic resonance imaging with intravascular magnetic resonance contrast media.
    Saeed M; Weber O; Lee R; Do L; Martin A; Saloner D; Ursell P; Robert P; Corot C; Higgins CB
    J Am Coll Cardiol; 2006 Nov; 48(10):1961-8. PubMed ID: 17112985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Gd-DOTA on fat quantification in skeletal muscle using two-point Dixon technique - preliminary data.
    Filli L; Ulbrich EJ; Guggenberger R; Boss A; Fischer MA; Del Grande F; Maurer B; Andreisek G
    Eur J Radiol; 2016 Jan; 85(1):131-135. PubMed ID: 26724657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosol deposition in the lungs of spontaneously breathing rats using Gd-DOTA-based contrast agents and ultra-short echo time MRI at 1.5 Tesla.
    Wang H; Sebrié C; Ruaud JP; Guillot G; Bouazizi-Verdier K; Willoquet G; Maître X; Darrasse L; de Rochefort L
    Magn Reson Med; 2016 Feb; 75(2):594-605. PubMed ID: 25809444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma.
    Grange C; Geninatti-Crich S; Esposito G; Alberti D; Tei L; Bussolati B; Aime S; Camussi G
    Cancer Res; 2010 Mar; 70(6):2180-90. PubMed ID: 20215497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of contrast enhancement in the pediatric spine at MR imaging with single- and triple-dose gadolinium.
    Tam JK; Bradley WG; Goergen SK; Chen DY; Pema PJ; Dubin MD; Teresi LM; Jordan JE
    Radiology; 1996 Jan; 198(1):273-8. PubMed ID: 8539393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.